Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Abilita Therapeutics
San Diego, California, USA
- Ownership
- Private
- Employees
- ~8
- Development stage
- Other
01
Overview
Abilita Therapeutics is a preclinical-stage biotechnology company using its EMP-directed evolution platform to generate stabilized versions of multi-span membrane proteins (GPCRs, ion channels, transporters) as reagents for structure-based discovery of therapeutic antibodies, nanobodies, and small molecules. Its internal pipeline is at preclinical research/lead optimization stage, supported by multiple NIH SBIR Phase I awards but with no disclosed clinical-stage assets.[1][4][5][6]
- Therapeutic areas
- OncologyNeurology
- Modalities
- Monoclonal antibodyAntibodyNanobody therapySingle-domain antibodyBiologicSmall molecule
- Industry
- Biotech
02
Partnerships
AmgenMultiple unnamed global pharma and public biotech partners using EMP technology for membrane protein–targeted discovery
Beyond the preview
Go deeper on Abilita Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Abilita Therapeutics.